Achilles Therapeutics Plc Stock Return On Equity
| ACHLDelisted Stock | USD 1.48 0.00 0.00% |
Fundamental analysis of Achilles Therapeutics allows traders to better anticipate movements in Achilles Therapeutics' stock price by examining its financial health and performance throughout various phases of its business cycle.
Achilles |
Achilles Therapeutics PLC Company Return On Equity Analysis
Achilles Therapeutics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Achilles Therapeutics Return On Equity | -0.52 |
Most of Achilles Therapeutics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Achilles Therapeutics PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Achilles Therapeutics PLC has a Return On Equity of -0.5212. This is 97.83% lower than that of the Biotechnology sector and 98.57% lower than that of the Health Care industry. The return on equity for all United States stocks is 68.13% higher than that of the company.
Achilles Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Achilles Therapeutics' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Achilles Therapeutics could also be used in its relative valuation, which is a method of valuing Achilles Therapeutics by comparing valuation metrics of similar companies.Achilles Therapeutics is currently under evaluation in return on equity category among its peers.
Achilles Fundamentals
| Return On Equity | -0.52 | |||
| Return On Asset | -0.3 | |||
| Current Valuation | (19.21 M) | |||
| Shares Outstanding | 41.1 M | |||
| Shares Owned By Insiders | 6.28 % | |||
| Shares Owned By Institutions | 83.09 % | |||
| Number Of Shares Shorted | 797.85 K | |||
| Price To Earning | 0.49 X | |||
| Price To Book | 0.59 X | |||
| EBITDA | (70.44 M) | |||
| Net Income | (69.94 M) | |||
| Cash And Equivalents | 201.6 M | |||
| Cash Per Share | 4.94 X | |||
| Total Debt | 4.62 M | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 11.45 X | |||
| Book Value Per Share | 2.51 X | |||
| Cash Flow From Operations | (48.45 M) | |||
| Short Ratio | 0.23 X | |||
| Earnings Per Share | (1.66) X | |||
| Price To Earnings To Growth | (0.31) X | |||
| Target Price | 0.5 | |||
| Number Of Employees | 204 | |||
| Beta | 1.25 | |||
| Market Capitalization | 63.22 M | |||
| Total Asset | 161.46 M | |||
| Retained Earnings | (259.95 M) | |||
| Working Capital | 128.64 M | |||
| Net Asset | 161.46 M |
About Achilles Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Achilles Therapeutics PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Achilles Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Achilles Therapeutics PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Achilles Stock
If you are still planning to invest in Achilles Therapeutics PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achilles Therapeutics' history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges |